PPLPHARMA Piramal Pharma Ltd US FDA Inspections Announcement 2024 - FDA Inspection Report Piramal Pharma Ltd announced the receipt of an Establishment Inspection Report (EIR) from the US FDA, indicating a successful inspection of its Ahmedabad manufacturing facility with no observations and a No Action Indicated status. This marks the formal closure of the inspection process..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Piramal Pharma Ltd